The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives
Global specialty pipeline accelerates growth
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The product will be marketed by Dr. Reddy's Laboratories Inc.
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Topiramate is indicated as a treatment of epilepsy and migraine
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
